| INTRODUC TI ON
Cullin-3, a cullin family protein, is a scaffold protein that forms a RING ubiquitin E3 ligase complex. Its adaptor proteins, BTBP, bridge CUL3 and substrate proteins leading to their ubiquitination.
1,2 CUL3/ BTBP/substrates axes are essential for development and regulate a variety of cellular functions (e.g. cell cycle progression, membrane trafficking, transcription, signaling in stress response, and cytoskeletal reorganization). Dysfunction of CUL3 has been implicated in the development of human diseases such as hypertension and cancer. 3, 4 CUL3 also regulates endothelial functions (e.g. cell proliferation and barrier function) and angiogenesis by formation of complexes with multiple BTBP. [5] [6] [7] [8] [9] Recently, we found that CUL3 or KCTD10, one of the BTBP, is essential for endothelial barrier functions in HUVEC. 7 Loss of CUL3 or KCTD10 induces strong actin polymerization and cell contraction, inhibiting the proper generation of endothelial barriers. 7 We also found that RhoB, an endosomal Rho GTPase, suppresses endothelial barrier formation in HUVEC. 7 An inhibitory role of RhoB in endothelial barrier formation was also implicated in TNFsimulated HUVEC and vascular endothelial cells in Crohn's disease. 10 Mechanistically, we found that RhoB was constitutively degraded in lysosomes, and the degradation process was mediated through K63 polyubiquitination at lysine 162 and 181 of RhoB by CUL3/ KCTD10. 7 Rac1, another Rho GTPase, is a central regulator of F-actin organization at the plasma membrane. Rac1 is translocated from endosomes to cell borders during endothelial barrier formation and stabilizes endothelial barriers in HUVEC. 10 Interestingly, the translocation of Rac1 was inhibited by high expression of RhoB, resulting in impaired barrier restoration. 10 Given our finding of the constitutive degradation of RhoB by CUL3/KCTD10, 7 CUL3/ KCTD10 may be critical for Rac1 trafficking and activation through RhoB degradation.
In addition to the physiological roles of Rac1 in endothelial cells, the oncogenic roles of Rac1 in various cancers have been recognized. 11 Elevated expression or hyperactivation of Rac1 is frequently observed in human cancers, correlating with their aggressiveness and poor prognosis. 12 NSC23766, a selective inhibitor of Rac1 activation, has been developed and was found to show anti-cancer effects in lymphoma. 13 In BC, both upregulation of Rac1 GEF and downregulation of Rac1 GAP have been reported. Overexpression of P-Rex1, a Rac1 GEF, played a critical role in metastasis of luminaltype BC. 14, 15 Low expression of SrGAP3, a Rac1/Cdc42 GAP, was observed in invasive ductal breast carcinomas. 16, 17 Downregulation of SrGAP3 enhanced anchorage-independent cell growth in a Rac1-dependent way in human mammary epithelial cells. 17 Activation of Rac1 contributed to trastuzumab (an inhibitory antibody to Human epidermal growth factor receptor 2 [HER2]) resistance which poses a serious problem during chemotherapy for HER2-positive BC. 18, 19 In the present study, we found that among the subtypes of human BC, high expression of Rac1 is correlated with poor prognosis, specifically of HER2-positive BC patients. We investigated the molecular mechanism underlying Rac1 activation in HER2-positive BC cells. Our results suggest that Rac1 activation requires downregulation of RhoB that is mediated by the CUL3/ KCTD10 E3 complex. supplemented with 10% FBS, 20 units/mL penicillin and 100 μg/mL streptomycin. Other Materials and Methods are described in Doc S1.
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| RE SULTS
| In HER2-positive BC, high expression of Rac1 mRNA significantly correlates with poor prognosis
We first examined whether the expression level of Rac1 correlates with the prognosis of human BC, the most common cancer in women, using the METABRIC database. were treated with siRNA oligos designed for CUL3 or KCTD10, and knockdown efficiency was confirmed by western blot (Figure 2A ).
We noticed that RhoB expression increased in cells depleted of CUL3 or KCTD10, suggesting that CUL3 and KCTD10 regulate the degradation of RhoB in SKBR-3 cells (Figure 2A ), as in HUVEC. 7 Expression of FLAG-tagged siRNA-resistant CUL3 or siRNA-resistant 
| Cullin-3/KCTD10 regulates plasma membrane dynamics of SKBR-3 cells
Given that knockdown of CUL3 or KCTD10 in SKBR-3 cells mostly abolished the activation of Rac1, as indicated by FRET analysis ( Figure 2C ), we reasoned that cellular events regulated by Rac1 would also be affected by knockdown of CUL3 or KCTD10. Because SKBR-3 cells formed dorsal membrane ruffles in response to EGF ( Figure 2D ) and the formation of dorsal membrane ruffles requires Rac1 activation, 25, 26 we examined whether knockdown of CUL3 or KCTD10 affects EGFinduced membrane ruffle formation at the dorsal cell surface.
We first examined the formation of membrane ruffles by phase- We next examined the fine architecture of the plasma membrane by SEM imaging. 27 Without EGF stimulation, we did not find Figure 3C ). These cells became flat with a smooth cell surface, consistent with the generation of lamellipodia, as indicated by phase-contrast microscopy ( Figure 3A ). 
F I G U R E 5
| Aberrant F-actin organization by CUL3-or KCTD10-depletion in SKBR-3 cells is Rac1-dependent
As membrane ruffle formation was accompanied by actin polymerization beneath the dorsal plasma membrane, 28 we expected that Figure S4A,B) . Together, these results suggest that Rac1 is essential for the formation not of lamellipodia but of dorsal membrane ruffle by EGF stimulation in SKBR-3 cells, and that aberrant membrane dynamics by CUL3-or KCTD10-knockdown is due to inability to activate Rac1 by EGF stimulation.
| Cullin-3/KCTD10 regulates F-actin organization in a RhoB-dependent manner
As shown (Figure 2A Figure 5B ; yellow arrows), as was seen in control cells.
The cell area of CUL3-or KCTD10-depleted cells was reduced by
RhoB knockdown compared to that of control cells ( Figure 5C ). In addition, enforced expression of RhoB exogenously in SKBR-3 cells inhibited the dorsal membrane ruffle formation ( Figure 5D ; yellow arrowheads). In contrast, SKBR-3 cells that did not overexpress RhoB normally formed membrane ruffles at the dorsal cell surface ( Figure 5D ; yellow arrows). These results suggest that aberrant Factin organization caused by CUL3 or KCTD10 knockdown is at least, in part, due to the accumulation of RhoB.
| Human epidermal growth factor receptor 2 signaling is required for generation of dorsal membrane ruffles and Rac1 activation
We examined whether HER2 signaling contributes to membrane Herceptin, compared to control cells ( Figure 6C ,D, Videos S7-S10).
These results suggest that HER2 is essential for EGF-induced Rac1 activation in SKBR-3 cells.
We then examined the relationship between HER2 signaling and CUL3/KCTD10-mediated RhoB degradation pathway. As shown ( Figure S6A ), knockdown of HER2 or lapatinib treatment did not affect the protein levels of CUL3, KCTD10, or RhoB in SKBR-3 cells ( Figure S6A ). EGF stimulation did not affect the expression levels of these proteins ( Figure S6A ). Intracellular localization of RhoB was not affected by HER2 knockdown ( Figure S6B ). Both EGFR and HER2 localized on the plasma membrane in CUL3 or KCTD10-depleted cells, as seen in control cells ( Figure S6C ). As HER2 depletion did not affect the amount of RhoB, the results suggest that HER2 signaling has a distinct site of action from CUL3/KCTD10.
| Cullin-3/KCTD10 is required for cell proliferation of SKBR-3 cells
Finally, as Rac1 activation is also known to regulate cell growth 11 and we found that Rac1 activation requires constitutive degradation of RhoB by CUL3/KCTD10 ubiquitin E3 complex, we hypothesized that CUL3 and KCTD10 regulate cell proliferation of SKBR-3 cells.
As expected, cell proliferation of SKBR-3 cells in the presence of upregulates gene expressions that are critical for EMT. [35] [36] [37] 39, 40 Recently, overexpression of HER2 was shown to deform the plasma membrane in a kinase activity-independent way, leading to disruption of normal epithelial morphology, 41 which argues an interesting possibility that the deformation contributes to the EMT of BC with high expression of HER2. In the present study, we found that HER2 is essential for the generation of dorsal membrane ruffles in SKBR-3 cells ( Figure 6 ). Dorsal membrane ruffle is a form of plasma membrane, frequently found in a motile cell surface. Ex vivo study using SKBR-3 cells suggested that Rac1 activation could be one of the molecular mechanisms underlying the development of trastuzumab resistance. Overexpression of CA Rac1 attenuated the efficacy of trastuzumab in SKBR-3 cells. 18 In contrast, treatment of SKBR-3 cells with NSC23766, a selective inhibitor of Rac1 activation, reduced trastuzumab resistance. 18, 19 In the present study, we found a novel CUL3-mediated molecular mechanism to regulate Rac1 activation. As Rac1 is also known to regulate cell proliferation through activation of mammalian target of rapamycin (mTOR) and p38/MAPK pathways, 49 and knockdown of CUL3 or 
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